2.9000
0.0000
(0.00%)
At close: January 29 at 3:00:00 PM EST
Research Analysis
Earnings Estimate
| Currency in USD | Current Qtr. (Jan 1970) | Next Qtr. (Jan 1970) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| No. of Analysts | -- | -- | -- | -- |
| Avg. Estimate | 0 | 0 | 0 | 0 |
| Low Estimate | 0 | 0 | 0 | 0 |
| High Estimate | 0 | 0 | 0 | 0 |
| Year Ago EPS | -- | -- | -- | -- |
Revenue Estimate
| Currency in USD | Current Qtr. (Jan 1970) | Next Qtr. (Jan 1970) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| No. of Analysts | -- | -- | 5 | 5 |
| Avg. Estimate | -- | -- | 54.96M | 95.23M |
| Low Estimate | -- | -- | 21.88M | 20.42M |
| High Estimate | -- | -- | 103.5M | 184M |
| Year Ago Sales | -- | -- | 61.64M | 54.96M |
| Sales Growth (year/est) | -- | -- | -10.83% | 73.26% |
EPS Trend
| Currency in USD | Current Qtr. (Jan 1970) | Next Qtr. (Jan 1970) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| Current Estimate | 0 | 0 | 0 | 0 |
| 7 Days Ago | 0 | 0 | 0 | 0 |
| 30 Days Ago | 0 | 0 | 0 | 0 |
| 60 Days Ago | 0 | 0 | 0 | 0 |
| 90 Days Ago | 0 | 0 | 0 | 0 |
EPS Revisions
| Currency in USD | Current Qtr. (Jan 1970) | Next Qtr. (Jan 1970) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| Up Last 7 Days | -- | -- | -- | -- |
| Up Last 30 Days | -- | -- | -- | -- |
| Down Last 7 Days | -- | -- | -- | -- |
| Down Last 30 Days | -- | -- | -- | -- |
Growth Estimates
| Current Qtr. | Next Qtr. | Current Year | Next Year | |
|---|---|---|---|---|
| IPHYF | -- | -- | -- | -- |
| S&P 500 | 9.01% | 10.57% | 14.00% | 13.70% |
Related Tickers
BOVNF BioInvent International AB (publ)
4.7000
0.00%
GNNSF Genscript Biotech Corporation
1.3550
0.00%
AAVXF ABIVAX Société Anonyme
5.99
-70.05%
SNBIF SanBio Company Limited
4.6500
0.00%
HNSBF Hansa Biopharma AB (publ)
3.0000
0.00%
PBIGF Paradigm Biopharmaceuticals Limited
0.3280
+10.85%
MLLCF Molecular Partners AG
4.2800
0.00%
ZSB.F Sirona Biochem Corp.
0.0345
+13.11%
ASCLF Ascletis Pharma Inc.
0.2393
0.00%
OXBDF Oxford Biomedica plc
5.56
0.00%